Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

This year’s flu season has raised heightened alarms among public health officials and experts specializing in infectious diseases. With reports indicating unusual patterns, concerns grow that this winter could witness one of the most severe influenza waves in recent memory.
According to coverage from the BBC, the U.K.’s National Health Service (NHS) has placed a call for urgent attention, signaling potential trouble ahead. The challenges posed by flu viruses this season could present significant health risks, particularly among vulnerable populations.
“This flu season is going to be unusually bad,” stated Dr. Jacob Glanville, CEO of Centivax, a biotechnology firm based in San Francisco. He underscored that the U.K. is experiencing an earlier and more severe outbreak this year, with reported cases tripling compared to the previous year.
Australia has recently experienced its most severe flu season on record in 2024, frequently serving as an indicator for what may unfold in the Northern Hemisphere. Early data from the United States mirrors these troubling trends, suggesting that the upcoming season may also be challenging.
Dr. Ravi Jhaveri, professor of pediatrics at the Northwestern University Feinberg School of Medicine and division head of pediatric infectious diseases at Ann & Robert H. Lurie Children’s Hospital of Chicago, noted signs of increasing flu activity across various parts of the country. He mentioned that vaccination rates have been declining since the pandemic, which may exacerbate the seasonal impact.
This combination of factors raises alarms for a potentially difficult flu season, especially with the increase of the H3N2 strain in circulation. This particular strain is historically associated with lower effectiveness of the influenza vaccine.
Dr. Glanville cautioned that the current vaccines contain viral strains that are outdated. He pointed out that they incorporate a mix of strains dating back to 2021, 2022, and 2023. This mismatch could result in lower efficacy in preventing flu infections this season.
The current H3N2 strain has a known history of causing more severe illnesses and higher hospitalization rates. The ongoing mutations of the flu virus continue to make it increasingly challenging for the immune system to recognize and combat it effectively.
Dr. Jhaveri explained how the flu virus consistently mutates, which is the primary reason why new vaccines are produced each year. Significantly, the flu appears to be spreading at an earlier stage than usual this year, adding to the uncertainty surrounding this season.
While historical patterns typically show flu activity rising following the peak circulation of RSV, Dr. Jhaveri noted that this year may exhibit a shift in how respiratory viruses interact. The advancements in prevention for RSV could be influencing the overall patterns of respiratory virus circulation.
Despite the potential challenges posed by the flu this year, health experts still advocate for vaccination. Dr. Glanville emphasized that while the protection offered may be limited, it is still a crucial step for public health. He noted that immunity typically increases after vaccination and natural infection, but that immunity tends to decline over time, particularly in older adults.
Dr. Jhaveri mentioned that based on data from Australia, vaccines should still offer the usual levels of protection against the flu. Therefore, getting vaccinated remains an essential strategy, especially for high-risk individuals.
Individuals with chronic conditions, weakened immune systems, obesity, pregnant women, and young children need to exercise extra caution during the flu season. Alarmingly, about half of the children who die from flu and its complications lack prior risk factors, underscoring the importance of vaccination as a preventive measure.
Dr. Jhaveri reiterated that vaccination is the first and vital step in protecting against flu and its complications.
For individuals hesitant to visit clinics for vaccination, a new nasal-spray vaccine has been approved for self-administration or for use by parents and caregivers at home. This innovative option could ease access to vaccinations, particularly for families facing challenges in scheduling clinic visits.
Looking to the future, Dr. Glanville shared that Centivax is working on developing a universal flu vaccine, with human trials set to commence in early 2026. Such advancements in vaccine technology may ultimately help address the yearly challenges the flu presents.
As the flu season approaches, maintaining vigilance and awareness is essential for public health. With the convergence of multiple factors contributing to an unusually bad season, experts stress the need for vaccination and preventative measures. The rise in flu activity this year highlights an important opportunity for individuals and communities to safeguard their health ahead of the cold winter months.
In summary, the emerging patterns of flu this season warrant serious attention. Early trends indicate a potentially severe season, with health officials urging the public to prioritize vaccination and remain proactive in protecting their health and that of their loved ones.